Thread: A new levodopa product could improve the treatment of advanced Parkinson's patients
View Single Post
Old 03-26-2013, 06:02 PM
sim00's Avatar
sim00 sim00 is offline
Member
  
Join Date: Jun 2011
Location: Italy
Posts: 192
10 yr Member
sim00 sim00 is offline
Member
sim00's Avatar
 
Join Date: Jun 2011
Location: Italy
Posts: 192
10 yr Member
Default A new levodopa product could improve the treatment of advanced Parkinson's patients
Orion Corporation presented promising Phase II data for new Parkinson's disease drug at AAN Annual Meeting

A new levodopa product (ODM-101) developed by Orion Corporation could improve the treatment of advanced Parkinson's disease patients. According to a Phase II study, presented yesterday at American Academy of Neurology's Annual Meeting in San Diego, ODM-101 significantly decreased daily OFF-time without increasing ON-time with troublesome dyskinesias compared to reference product StalevoŽ, which is an established standard medication for advanced Parkinson's patients experiencing so-called end-of-dose wearing off symptoms associated with levodopa therapy

http://www.orion.fi/en/News-and-medi...rchive/2013/3/
__________________
Sim00

Born in 1969, diagnosed PD in 2007, first symptoms 2004. DBS in July 2016.
sim00 is offline   Reply With QuoteReply With Quote